These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17498392

  • 1. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
    Lee JH, Lee MG.
    J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ, Kim YC, Park KJ, Kim DS, Kwon JW, Kim WB, Lee MG.
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [Abstract] [Full Text] [Related]

  • 3. Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
    Kim EJ, Bae SK, Kim HJ, Kim YG, Kim SO, Lee DH, Lim H, Lee MG.
    J Pharm Sci; 2003 May; 92(5):1112-24. PubMed ID: 12712431
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS, Bae SK, Lee MG.
    Int J Pharm; 2006 Aug 31; 320(1-2):64-70. PubMed ID: 16730145
    [Abstract] [Full Text] [Related]

  • 5. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Lee MH, Bae SK, Kim EJ, Kim YG, Kim SO, Lee DH, Lim H, Yoo SE, Lee MG.
    J Pharm Sci; 2003 Jan 31; 92(1):190-201. PubMed ID: 12486695
    [Abstract] [Full Text] [Related]

  • 6. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH, Kim SG, Lee MG.
    J Pharm Sci; 2006 Nov 31; 95(11):2543-52. PubMed ID: 16937336
    [Abstract] [Full Text] [Related]

  • 7. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH, Lee MG.
    Int J Pharm; 2007 Mar 06; 332(1-2):17-23. PubMed ID: 17157458
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH, Lee MG.
    Life Sci; 2002 Feb 01; 70(11):1299-315. PubMed ID: 11883708
    [Abstract] [Full Text] [Related]

  • 11. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH, Lee MG.
    Biopharm Drug Dispos; 2008 Oct 01; 29(7):414-26. PubMed ID: 18697186
    [Abstract] [Full Text] [Related]

  • 12. Time-dependent effects of Klebsiella pneumoniae endotoxin on the telithromycin pharmacokinetics in rats; restoration of the parameters in 96-hour KPLPS rats to the control levels.
    Lee JH, Cho YK, Jung YS, Kim YC, Lee MG.
    Pulm Pharmacol Ther; 2008 Dec 01; 21(6):860-5. PubMed ID: 18976719
    [Abstract] [Full Text] [Related]

  • 13. Effects of Escherichia coli lipopolysaccharide on telithromycin pharmacokinetics in rats: inhibition of metabolism via CYP3A.
    Lee JH, Cho YK, Jung YS, Kim YC, Lee MG.
    Antimicrob Agents Chemother; 2008 Mar 01; 52(3):1046-51. PubMed ID: 18160519
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.
    Chung HJ, Lee JH, Woo SJ, Park HK, Koo CH, Lee MG.
    Biopharm Drug Dispos; 2007 May 01; 28(4):187-97. PubMed ID: 17377948
    [Abstract] [Full Text] [Related]

  • 15. Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin.
    Lee JH, Lee MG.
    Biopharm Drug Dispos; 2007 May 01; 28(4):157-66. PubMed ID: 17377958
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect.
    Bae SK, Yang KH, Aryal DK, Kim YG, Lee MG.
    J Pharm Sci; 2009 Apr 01; 98(4):1587-601. PubMed ID: 18780336
    [Abstract] [Full Text] [Related]

  • 17. Involvement of intestinal permeability in the oral absorption of clarithromycin and telithromycin.
    Togami K, Hayashi Y, Chono S, Morimoto K.
    Biopharm Drug Dispos; 2014 Sep 01; 35(6):321-9. PubMed ID: 24801141
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS, Choi MK, Kim JS, Shim CK, Chung SJ, Kim DD.
    Xenobiotica; 2011 Mar 01; 41(3):243-51. PubMed ID: 21128757
    [Abstract] [Full Text] [Related]

  • 19. Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats.
    Kim J, Han KS, Lee JW, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1998 Nov 01; 102(2):125-36. PubMed ID: 10100504
    [Abstract] [Full Text] [Related]

  • 20. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.
    Shin JH, Choi KY, Kim YC, Lee MG.
    Antimicrob Agents Chemother; 2004 May 01; 48(5):1756-62. PubMed ID: 15105131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.